Literature DB >> 9289864

Radiotherapy is a necessary adjuvant in the treatment of early breast cancer.

S H Levitt.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9289864     DOI： 10.1007/bf03038323

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Post-mastectomy megavoltage radiotherapy: the Oslo and Stockholm trials.

Authors:  A Auquier; L E Rutqvist; H Høst; S Rotstein; R Arriagada
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence.

Authors:  H Kemperman; J Borger; A Hart; H Peterse; H Bartelink; J van Dongen
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

3.  The importance of local control in the conservative treatment of breast cancer.

Authors:  S H Levitt; D M Aeppli; M E Nierengarten
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

4.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.

Authors:  A P Forrest; H J Stewart; D Everington; R J Prescott; C S McArdle; A N Harnett; D C Smith; W D George
Journal:  Lancet       Date:  1996-09-14       Impact factor: 79.321

5.  Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.

Authors:  T Whelan; R Clark; R Roberts; M Levine; G Foster
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-08-30       Impact factor: 7.038

6.  A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.

Authors:  S J Schnitt; J Hayman; R Gelman; T J Eberlein; S M Love; K Mayzel; R T Osteen; A J Nixon; S Pierce; J L Connolly; P Cohen; L Schneider; B Silver; A Recht; J R Harris
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860
  6 in total
  1 in total

1.  [Postoperative radiotherapy in high risk patients with breast cancer and adjuvant chemotherapy].

Authors:  V Budach; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.